Weipeng Zhao

1.6k total citations
67 papers, 1.1k citations indexed

About

Weipeng Zhao is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Weipeng Zhao has authored 67 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 19 papers in Oncology and 15 papers in Cancer Research. Recurrent topics in Weipeng Zhao's work include Cardiac Valve Diseases and Treatments (6 papers), Cardiovascular Function and Risk Factors (6 papers) and HER2/EGFR in Cancer Research (6 papers). Weipeng Zhao is often cited by papers focused on Cardiac Valve Diseases and Treatments (6 papers), Cardiovascular Function and Risk Factors (6 papers) and HER2/EGFR in Cancer Research (6 papers). Weipeng Zhao collaborates with scholars based in China, United States and France. Weipeng Zhao's co-authors include Amer A. Beg, Eric B. Haura, Scott Antonia, Michael T. Massengill, Brian Ruffell, David Noyes, Hong Zheng, Xiubao Ren, Mengyu Xie and Cihui Yan and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Weipeng Zhao

60 papers receiving 1.1k citations

Peers

Weipeng Zhao
Bethany A. Kerr United States
Weipeng Zhao
Citations per year, relative to Weipeng Zhao Weipeng Zhao (= 1×) peers Bethany A. Kerr

Countries citing papers authored by Weipeng Zhao

Since Specialization
Citations

This map shows the geographic impact of Weipeng Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weipeng Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weipeng Zhao more than expected).

Fields of papers citing papers by Weipeng Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weipeng Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weipeng Zhao. The network helps show where Weipeng Zhao may publish in the future.

Co-authorship network of co-authors of Weipeng Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Weipeng Zhao. A scholar is included among the top collaborators of Weipeng Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weipeng Zhao. Weipeng Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yongan, Mili Liu, Yu Jia, et al.. (2025). Membrane-free and low-voltage oxygen generator using metal hydride mediated water splitting. Nano Energy. 140. 111013–111013. 3 indexed citations
2.
Hu, Chunqiang, Wei Li, Wenzhi Pan, et al.. (2024). 2-year results and myocardial impact of transapical mitral valve repair in patients with primary mitral regurgitation: an echocardiographic study. Journal of Cardiothoracic Surgery. 19(1). 403–403. 1 indexed citations
3.
Zhu, Hao, You Zhou, Yu Liu, et al.. (2024). Continuous 3D Myocardial Motion Tracking via Echocardiography. IEEE Transactions on Medical Imaging. 43(12). 4236–4252. 1 indexed citations
4.
Zhao, Weipeng, Qicheng Zhang, Yuanzhi Zhu, et al.. (2023). Boosting Reaction Kinetics and Mass Transfer of Bifunctional Co‐Based Oxygen Electrocatalyst Prepared from CoAl‐LDH. Advanced Energy Materials. 13(35). 29 indexed citations
5.
Zhao, Weipeng, et al.. (2023). Gene-echocardiography: refining genotype–phenotype correlations in hypertrophic cardiomyopathy. European Heart Journal - Cardiovascular Imaging. 25(1). 127–135. 13 indexed citations
6.
Hu, Jiayue, Ronggang Lang, Weipeng Zhao, et al.. (2023). The mixed subtype has a worse prognosis than other histological subtypes: a retrospective analysis of 217 patients with metaplastic breast cancer. Breast Cancer Research and Treatment. 200(1). 23–36. 7 indexed citations
7.
Zhao, Weipeng, et al.. (2022). Ado-trastuzumab emtansine in the treatment of lung adenocarcinoma with ERBB2 mutation: a case report and literature review. Anti-Cancer Drugs. 33(8). 773–777. 2 indexed citations
8.
Li, Dan, et al.. (2022). Chinese Medicinal Herb-Derived Carbon Dots for Common Diseases: Efficacies and Potential Mechanisms. Frontiers in Pharmacology. 13. 815479–815479. 25 indexed citations
9.
Wang, Xiaorui, et al.. (2022). Analysis of Clinical Characteristics, Treatment, and Prognostic Factors of 106 Breast Cancer Patients With Solitary Pulmonary Nodules. Frontiers in Surgery. 9. 843913–843913. 4 indexed citations
10.
Zhao, Weipeng, Linlin Sun, Xichuan Li, et al.. (2021). SCD5 expression correlates with prognosis and response to neoadjuvant chemotherapy in breast cancer. Scientific Reports. 11(1). 8976–8976. 14 indexed citations
11.
Xu, Jie, et al.. (2019). Overexpression of ANLN in lung adenocarcinoma is associated with metastasis. Thoracic Cancer. 10(8). 1702–1709. 50 indexed citations
12.
Wang, Jingfeng, Zhiming Li, Yanyan Wang, et al.. (2017). Qiliqiangxin Enhances Cardiac Glucose Metabolism and Improves Diastolic Function in Spontaneously Hypertensive Rats. Evidence-based Complementary and Alternative Medicine. 2017(1). 3197320–3197320. 14 indexed citations
13.
Zheng, Hong, Weipeng Zhao, Cihui Yan, et al.. (2016). HDAC Inhibitors Enhance T-Cell Chemokine Expression and Augment Response to PD-1 Immunotherapy in Lung Adenocarcinoma. Clinical Cancer Research. 22(16). 4119–4132. 264 indexed citations
14.
Sun, Xiaotian, Jun Li, Weipeng Zhao, et al.. (2015). Early Assistance With Left Ventricular Assist Device Limits Left Ventricular Remodeling After Acute Myocardial Infarction in a Swine Model. Artificial Organs. 40(3). 243–251. 24 indexed citations
15.
Wei, Lai, Huan Liu, Li Zhu, et al.. (2015). A New Transcatheter Aortic Valve Replacement System for Predominant Aortic Regurgitation Implantation of the J-Valve and Early Outcome. JACC: Cardiovascular Interventions. 8(14). 1831–1841. 47 indexed citations
16.
Shu, Xianhong, Yili Liu, Hong Shen, et al.. (2015). A Novel Method for Sensitive Determination of Subclinical Left-Ventricular Systolic Dysfunction in Subjects With Obstructive Sleep Apnea. Respiratory Care. 61(3). 366–375. 17 indexed citations
17.
Hopewell, Emily, Weipeng Zhao, William J. Fulp, et al.. (2013). Lung tumor NF-κB signaling promotes T cell–mediated immune surveillance. Journal of Clinical Investigation. 123(6). 2509–2522. 88 indexed citations
18.
Zhang, Yizhuo, Qing Guo, Haifeng Zhao, et al.. (2012). Expression of CXCR4 is an independent prognostic factor for overall survival and progression-free survival in patients with myelodysplastic syndrome. Medical Oncology. 30(1). 341–341. 8 indexed citations
19.
Zhang, Yizhuo, Dandan Zhao, Haifeng Zhao, et al.. (2012). Hypermethylation of SHP-1 promoter in patient with high-risk myelodysplastic syndrome and it predicts poor prognosis. Medical Oncology. 29(4). 2359–2363. 12 indexed citations
20.
Dong, Lili, Cuizhen Pan, Weipeng Zhao, & Xianhong Shu. (2011). A Traumatic Rupture of Valsalva Sinus With Dissection Into the Interventricular Septum. Journal of the American College of Cardiology. 57(23). e373–e373. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026